Probiotic Bacteria Regulate Intestinal Epithelial Permeability in Experimental Ileitis by a TNF-Dependent Mechanism

被引:87
作者
Corridoni, Daniele [1 ]
Pastorelli, Luca [2 ]
Mattioli, Benedetta [2 ]
Locovei, Silviu [1 ,2 ]
Ishikawa, Dai [1 ]
Arseneau, Kristen O. [1 ]
Chieppa, Marcello [3 ]
Cominelli, Fabio [1 ]
Pizarro, Theresa T. [2 ]
机构
[1] Case Western Reserve Univ, Sch Med, Dept Med, Div Gastroenterol & Liver Dis, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA
[3] Inst Ricovero & Cura Carattere Sci IRCCS De Belli, Lab Expt Immunopathol, Bari, Italy
来源
PLOS ONE | 2012年 / 7卷 / 07期
基金
美国国家卫生研究院;
关键词
TUMOR-NECROSIS-FACTOR; INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; TIGHT JUNCTION; ULCERATIVE-COLITIS; BARRIER FUNCTION; FACTOR-ALPHA; SAMP1/YITFC MOUSE; SPONTANEOUS MODEL; INTERFERON-GAMMA;
D O I
10.1371/journal.pone.0042067
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: We previously showed that the probiotic mixture, VSL#3, prevents the onset of ileitis in SAMP/YitFc (SAMP) mice, and this effect was associated with stimulation of epithelial-derived TNF. The aim of this study was to determine the mechanism(s) of VSL#3-mediated protection on epithelial barrier function and to further investigate the "paradoxical" effects of TNF in preventing SAMP ileitis. Methods: Permeability was evaluated in SAMP mice prior to the onset of inflammation and during established disease by measuring transepithelial electrical resistance (TEER) on ex vivo-cultured ilea following exposure to VSL#3 conditioned media (CM), TNF or VSL#3-CM + anti-TNF. Tight junction (TJ) proteins were assessed by qRT-PCR, Western blot, and confocal microscopy, and TNFRI/TNFRII expression measured in freshly isolated intestinal epithelial cells (IEC) from SAMP and control AKR mice. Results: Culture with either VSL#3-CM or TNF resulted in decreased ileal paracellular permeability in pre-inflamed SAMP, but not SAMP with established disease, while addition of anti-TNF abrogated these effects. Modulation of the TJ proteins, claudin-2 and occludin, occurred with a significant decrease in claudin-2 and increase in occludin following stimulation with VSL#3-CM or TNF. TNF protein levels increased in supernatants of SAMP ilea incubated with VSL#3-CM compared to vehicle, while IEC-derived TNFR mRNA expression decreased in young, and was elevated in inflamed, SAMP versus AKR mice. Conclusions: Our data demonstrate that the previously established efficacy of VSL#3 in preventing SAMP ileitis is due to direct innate and homeostatic effects of TNF on the gut epithelium, modulation of the TJ proteins, claudin-2 and occludin, and overall improvement of intestinal permeability.
引用
收藏
页数:10
相关论文
共 60 条
[1]   INTESTINAL PERMEABILITY OF CR-15-LABELED ETHYLENEDIAMINETETRAACETIC ACID IN PATIENTS WITH CROHNS-DISEASE AND THEIR HEALTHY RELATIVES [J].
AINSWORTH, M ;
ERIKSEN, J ;
RASMUSSEN, JW ;
DEMUCKADELL, OBS .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1989, 24 (08) :993-998
[2]   Innate and adaptive immune responses related to IBD pathogenesis [J].
Arseneau K.O. ;
Tamagawa H. ;
Pizarro T.T. ;
Cominelli F. .
Current Gastroenterology Reports, 2007, 9 (6) :508-512
[3]   Medical therapies for ulcerative colitis and Crohn's disease. [J].
Baert F.J. ;
Rutgeerts P.J. .
Current Gastroenterology Reports, 2000, 2 (6) :446-450
[4]   Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein [J].
Balda, MS ;
Whitney, JA ;
Flores, C ;
Gonzalez, S ;
Cereijido, M ;
Matter, K .
JOURNAL OF CELL BIOLOGY, 1996, 134 (04) :1031-1049
[5]   VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis [J].
Bibiloni, R ;
Fedorak, RN ;
Tannock, GW ;
Madsen, KL ;
Gionchetti, P ;
Campieri, M ;
De Simone, C ;
Sartor, RB .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (07) :1539-1546
[6]   Tumor necrosis factor α-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis [J].
Bohan, A ;
Chen, WS ;
Denson, LA ;
Held, MA ;
Boyer, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (38) :36688-36698
[7]   Spotlight on VSL#3 probiotic mixture in chronic inflammatory bowel diseases [J].
Chapman, Therese M. ;
Plosker, Greg L. ;
Figgitt, David P. .
BIODRUGS, 2007, 21 (01) :61-63
[8]   Defects in mucosal immunity leading to Crohn's disease [J].
Cobrin, GM ;
Abreu, MT .
IMMUNOLOGICAL REVIEWS, 2005, 206 :277-295
[9]   Cytokine-based therapies for Crohn's disease - New paradigms [J].
Cominelli, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (20) :2045-2048
[10]   Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial [J].
D'Haens, G ;
Van Deventer, S ;
Van Hogezand, R ;
Chalmers, D ;
Kothe, C ;
Baert, F ;
Braakman, T ;
Schaible, T ;
Geboes, K ;
Rutgeerts, P .
GASTROENTEROLOGY, 1999, 116 (05) :1029-1034